Hydrogenology
Source-linked study record

Hydrogen gas distribution in organs after inhalation: Real-time monitoring of tissue hydrogen concentration in rat

Yamamoto R, Homma K, Suzuki S, Sano M, Sasaki J. · Scientific Reports. 2019;9:1255.

PreclinicalInhaled H₂Published 2019Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Anesthetized eight-week-old male Sprague-Dawley rats.

Intervention and dose

Continuous gas inhalation through a face/head hood until the selected tissue reached a concentration plateau, followed by monitoring until return to baseline. · 3% H₂ in air at a validated total flow of 0.2 L/min.

Duration

H₂ continued until tissue saturation; median timing was organ-specific, with saturation at about 6.3–9.4 minutes in brain, liver, kidney and mesenteric fat and 20.1 minutes in thigh muscle.

Reported result

Maximum concentration was highest in liver (29.0±2.6 µmol/L) and lowest in kidney (18.0±2.2 µmol/L). Muscle saturated more slowly than all other tested tissues; onset delay was similar across organs. The study measured distribution, not therapeutic benefit.

Main limitation

Distribution study in anesthetized male rats, one concentration/route, no therapeutic outcome, different animals for different organs, no arterial-blood H₂ measurement and occasional small negative sensor values attributed to measurement effects. A Japanese KAKENHI grant supported the work; no commercial conflict statement was identified on the publisher page, so absence of conflicts is not inferred.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

In-vivo pharmacokinetic/distribution experiment with real-time microsensor monitoring

Research topic

Other molecular hydrogen research

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Anesthetized eight-week-old male Sprague-Dawley rats.

Sample

One organ was monitored per animal; assay counts were brain n=8, liver n=6, kidney n=5, mesenteric fat n=4 and thigh muscle n=5. The article does not state a consolidated unique-rat total.

Duration

H₂ continued until tissue saturation; median timing was organ-specific, with saturation at about 6.3–9.4 minutes in brain, liver, kidney and mesenteric fat and 20.1 minutes in thigh muscle.

Intervention

Continuous gas inhalation through a face/head hood until the selected tissue reached a concentration plateau, followed by monitoring until return to baseline.

Hydrogen form

H₂ alone mixed into air — not Brown's gas.

Dose or H₂ specification

3% H₂ in air at a validated total flow of 0.2 L/min.

H₂ flow

6 mL/min H₂, calculated from 200 mL/min total flow × 3% H₂.

O₂ delivered with H₂

Approximately 21% O₂ in the air carrier; approximately 42 mL/min O₂ calculated from 200 mL/min × 21%.

Comparator

Within-study comparison across organs and tissues; there was no separate non-H₂ control group for the concentration curves.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Maximum tissue H₂ concentration, time to 10%, 63%, 90% and full saturation, and washout dynamics in brain, liver, kidney, mesenteric fat and thigh muscle.

Reported result

Maximum concentration was highest in liver (29.0±2.6 µmol/L) and lowest in kidney (18.0±2.2 µmol/L). Muscle saturated more slowly than all other tested tissues; onset delay was similar across organs. The study measured distribution, not therapeutic benefit.

Extraction completeness

The complete open-access publisher article, gas concentration and flow, assay counts, all principal distribution results, measurement limitations, funding and author disclosures were checked.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Distribution study in anesthetized male rats, one concentration/route, no therapeutic outcome, different animals for different organs, no arterial-blood H₂ measurement and occasional small negative sensor values attributed to measurement effects. A Japanese KAKENHI grant supported the work; no commercial conflict statement was identified on the publisher page, so absence of conflicts is not inferred.

Applies directly to

Describes tissue exposure kinetics under this rat protocol; it does not establish an effective or safe clinical dose.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 30718910 · DOI: 10.1038/s41598-018-38180-4

Publisher access

Open-access Scientific Reports article and PubMed Central copy.

Extraction basis

Scientific Reports publisher article, PubMed Central copy and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.